Point: Fluoroquinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Cancer Patients Works for Defined Outcomes in Defined Populations, but Must Be Used Wisely

Author： Bow Eric J.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.2, Iss.5, 2004-09, pp. : 433-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Counterpoint: Routine Anti-Bacterial Prophylaxis Is Not Indicated in Neutropenic Patients With Hematological Malignancies

By Kleinberg Michael  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 5, 2004-09 ,pp. : 445-451

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Antivirals Used for Influenza Chemoprophylaxis

By  

Current Medicinal Chemistry, Vol. 19, Iss. 35, 2012-12 ,pp. : 5947-5956

Bentham Science Publishers

Access to resources Recommend Favorite

Antibacterial Activity of Lipophilic Fluoroquinolone Derivatives

By  

Medicinal Chemistry, Vol. 5, Iss. 5, 2009-09 ,pp. : 419-421

Bentham Science Publishers

Access to resources Recommend Favorite

Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer

By CARR DAVID R.   TREVINO JULIAN J.   DONNELLY HEIDI B.  

Dermatologic Surgery, Vol. 37, Iss. 2, 2011-02 ,pp. : 129-145

Elsevier

Access to resources Recommend Favorite

Genetically defined hyperlipidemia

By Smit Jan WA   Diamant Michaela  

Pharmacogenomics, Vol. 5, Iss. 3, 2004-04 ,pp. : 295-304

Future Medicine

Access to resources Recommend Favorite